Skip to main content

Animations

MJFF Publications

3951 - 3975 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2011
  • 2011
  • 2015
  • 2017
  • 2017
  • 2010
  • 2009
  • 2011
  • 2011
  • 2014
  • 2012
  • 2018
  • 2015
  • 2008
  • 2012
  • 2017
  • 2016
  • 2012
  • 2018
  • 2004
  • 2017
  • 2005
  • 2012
  • 2011
  • Summary Details
    OPEN
    Title: Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0021-5
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?
    Journal Name: Neurosurgery
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1227/neu.0b013e3182160456
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice
    Journal Name: Molecular and Cellular Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.mcn.2011.05.006
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping
    Journal Name: Nature Protocols
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nprot.2015.122
    Citation Count: 258
  • Summary Details
    OPEN
    Title: LRRK2 levels in immune cells are increased in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0010-8
    Citation Count: 237
  • Summary Details
    OPEN
    Title: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0007-3
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008
    Citation Count: 185
  • Summary Details
    OPEN
    Title: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-009-9140-z
    Citation Count: 234
  • Summary Details
    OPEN
    Title: The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-010-0513-5
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awr165
    Citation Count: 134
  • Summary Details
    OPEN
    Title: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
    Journal Name: Applied Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/app4010066
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Discovery of Potent, Novel Nrf2 Inducers Via Quantum Modeling, Virtual Screening, and In Vitro Experimental Validation
    Journal Name: Chemical Biology & Drug Design
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cbdd.12040
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Increasing the use of mobile technology–derived endpoints in clinical trials
    Journal Name: Clinical Trials
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1740774518755393
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.10.028
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0705363105
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/dds161
    Citation Count: 226
  • Summary Details
    OPEN
    Title: The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-016-0002-0
    Citation Count: 475
  • Summary Details
    OPEN
    Title: The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2016.12.013
    Citation Count: 238
  • Summary Details
    OPEN
    Title: Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1217296110
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-35464-7
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0405313101
    Citation Count: 324
  • Summary Details
    OPEN
    Title: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-017-1792-9
    Citation Count: 184
  • Summary Details
    OPEN
    Title: CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1471-4159.2005.03428.x
    Citation Count: 285
  • Summary Details
    OPEN
    Title: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25213
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2011.08.009
    Citation Count: 286
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.